Shoulder Innovations, Inc. (NYSE:SI) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shoulder Innovations, Inc. (NYSE:SI) has received a consensus rating of “Moderate Buy” from the seven analysts that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $21.00.

SI has been the topic of a number of research analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Shoulder Innovations in a report on Monday, June 29th. Piper Sandler reissued an “overweight” rating and issued a $19.00 target price (up from $18.00) on shares of Shoulder Innovations in a research report on Friday, May 8th.

Insiders Place Their Bets

In related news, COO Matthew Fraser Ahearn sold 15,856 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $18.68, for a total value of $296,190.08. Following the sale, the chief operating officer owned 273,320 shares in the company, valued at approximately $5,105,617.60. This trade represents a 5.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 29.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of SI. Sectoral Asset Management Inc. grew its stake in shares of Shoulder Innovations by 14.4% during the 4th quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock valued at $7,042,000 after purchasing an additional 62,153 shares during the period. Deerfield Management Company L.P. purchased a new position in shares of Shoulder Innovations in the third quarter worth approximately $6,056,000. Alyeska Investment Group L.P. bought a new stake in Shoulder Innovations during the third quarter valued at approximately $5,667,000. Roubaix Capital LLC increased its holdings in Shoulder Innovations by 61.9% during the first quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock valued at $3,736,000 after buying an additional 98,305 shares during the last quarter. Finally, Vanguard Group Inc. bought a new position in Shoulder Innovations in the third quarter worth approximately $1,836,000.

Shoulder Innovations Trading Down 0.4%

NYSE:SI opened at $20.22 on Friday. The stock has a market cap of $419.36 million and a price-to-earnings ratio of -0.12. The company has a quick ratio of 10.04, a current ratio of 11.81 and a debt-to-equity ratio of 0.11. The company’s 50 day moving average price is $18.29 and its 200-day moving average price is $15.46. Shoulder Innovations has a 52 week low of $10.92 and a 52 week high of $23.00.

Shoulder Innovations (NYSE:SI) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.03. The business had revenue of $16.71 million for the quarter. Shoulder Innovations had a negative return on equity of 35.11% and a negative net margin of 81.78%. On average, equities research analysts forecast that Shoulder Innovations will post -1.67 earnings per share for the current fiscal year.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.